Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
C.G. Child, J.G. Turcotte.
Surgery and portal hypertension. En: Child CG 3rd, ed. The Liver and Portal Hypertension. Volume 1. Major Problems in Clinical Surgery.
pp. 1-85
[2.]
R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson, M.C. Pietroni, R. Williams.
Transection of the oesophagus for bleeding esophageal varices.
Brit J Surgery, 60 (1973), pp. 646-649
[3.]
C. Pagliari.
Meld: the end of Child-Pugh classification?.
J Hepatology, 36 (2002), pp. 141-142
[4.]
P. Schlichting, E. Christensen, P.K. Andersen, L. Fauerholdt, E. Juhl, H. Poulsen, et al.
Prognostic factors in cirrhosis identified by Cox's regression model.
Hepatology, 3 (1983), pp. 889-895
[5.]
P. Ginés, E. Quintero, V. Arroyo, J. Terés, M. Bruguera, A. Rimola, et al.
Compensated cirrhosis: natural history and prognostic factors.
Hepatology, 7 (1987), pp. 122-128
[6.]
C. Infante-Rivard, S. Esnaola, J.P. Villeneuve.
Clinical and statistical validity of conventional prognostic factors in predicting short-term survivial among cirrhotics.
Hepatology, 7 (1987), pp. 660-664
[7.]
E. Christensen.
Prognostic models in chronic liver disease: validity, usefulness and future role.
J Hepatol, 26 (1997), pp. 1414-1424
[8.]
A. Reuben.
Child comes of age.
Hepatology, 35 (2002), pp. 244-245
[9.]
M. Malinchoc, P.S. Kamath, F.D. Gordon, C.J. Peine, P. Rank.
Borg PCJ. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.
Hepatology, 31 (2000), pp. 864-871
[10.]
P.S. Kamath, R.H. Wiesner, M. Malinchoc, W. Kremers, T.M. Therneau, C.L. Kosberg, et al.
A model to predict survival in patients with end-stage liver disease.
Hepatology, 33 (2001), pp. 464-470
[11.]
R.H. Wiesner, S.V. McDiarmid, P.S. Kamath, E.B. Edwards, M. Malinchoc, W.K. Kremers, et al.
MELD and PELD: application of survival models to liver allocation.
Liver Transpl, 7 (2001), pp. 567-568
[12.]
Model for End Stage Liver Disease (MELD) and Pediatric End-Stage Liver Disease (PELD) Calculator. Disponible en: http://www.unos.org/frame_Default.asp?Category=Resources
[13.]
L. Lladó, J. Figueras, R. Memba, X. Xiol, C. Baliellas, S. Vázquez, et al.
Is MELD really the definitive score for liver allocation?.
Liver Transpl, 8 (2002), pp. 795-798
[14.]
M. Ortiz, V. Vargas, J. Roselló, E. Hidalgo, L.l. Castells, C. Margarit, et al.
¿Es más útil el MELD que el Pugh-Child en pacientes candidatos a trasplante hepático?.
Gastroenterol Hepatol, 25 (2002), pp. 136
[15.]
R.H. Wiesner, F. Edwards, R. Freeman, A. Harper, R. Kim, P. Kamath, et al.
Model for end-stage liver disease (MELD) and allocation of donor livers.
Gastroenterology, 124 (2003), pp. 91-96
[16.]
R. Brown, S. Kumar, M. Russo, M. Kinkhabwala, D. Rudow, P. Harren, et al.
Model for End-Stage Liver Disease and Child-Turcotte-Pugh Score as Predictors of Pretransplantation Disease Severity, Posttransplantation Outcome, and Resource Utilization in United Network for Organ Sharing Status 2A Patients.
Liver Transpl, 3 (2002), pp. 278-284
[17.]
R.B. Freeman, R.J. Rohrer, E. Katz, W.D. Lewis, R.L. Jenkins, A.B. Cosimi, et al.
Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time.
Liver Transpl, 7 (2002), pp. 173-178
[18.]
S.J. Cheng, R.B. Freeman, J.B. Wong.
Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma.
Liver Transpl, 8 (2002), pp. 323-328
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
